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Structures are reported for complexes between Rab27 and the Rab27-binding domains of two molecules in-
volved in successive steps in melanosome transport. Comparison of the Rab27B:Slac2-a (Chavas et al.,
2008) and Rab27A:Slp2-a (Kukimoto-Niino et al., 2008) structures with that of the Rab3A:Rabphilin complex
gives important clues to the specificity of the interactions.Structure 16, October 8, 2008 ª2008 Elsevier Ltd All rights reserved 1437Rab proteins are essential regulators of
the important process of intracellular
vesicular transport (Zerial and McBride,
2001). Paramount among the multiple
tasks they fulfill is the physical connection
of transport vesicles to motor systems to
allow the actual movement from a donor
to an acceptor membrane, and, once
there, the specific recognition of a mem-
brane or membrane domain before fusion
of thevesiclesand themembranesoccurs.
One of the over 60 members of the human
Rab family, Rab27 has attracted much at-
tention in recent years, partly because of
its role in several diseases, including Gris-
celli syndrome (Seabra et al., 2002). There
are two closely related Rab27 homologs,
Rab27A and Rab27B, which appear to
play similar but not identical roles, with
cell-type specific expression of Rab27B
being more restricted. Rab27 is attached
by twoC-terminal geranylgeranyl residues
to secretory granules in many secretory
cells and to pigment-containing melano-
somes in melanocytes. The final stage of
transport of melanosomes to the dendritic
regions of the cell occurs on actin fila-
ments. This happens via Rab27A interac-
tion with Slac2-a (melanophilin), which in
turn binds to the motor-protein myosin
Va. In Griscelli syndrome (GS), there are
genetic defects in myosin Va (GS1),
Rab27 (GS2) or melanophilin (GS3). All
forms are characterized by hypopigmen-
tation, with additional severe immunodefi-
ciency and neurological defects in GS2.
Furthermore, Rab27A plays a role in the
process of docking to the plasma mem-
brane. The secondRab27 effector protein,
Slp2-a (exophilin 4), interacts via its effec-
tor domain with Rab27 and via its 2 C-ter-
minal C2 domains to the lipid phosphati-
dylserine in the plasma membrane. Thus,
two different Rab27 effector proteins are
involved in two successive steps of thetransport mechanism. In this issue of
Structure, structures of theRab27-binding
regions of Slac2-a and Slp2-a bound to
Rab27 are presented.
Slac2-a and Slp2-a both have their
Rab27-binding domains (referred to as
SHD [for Slp-homology domains], or
more specifically as RBD27 domains)
near or at their N terminus. These consist
of two a-helical regions linked either
directly (Slp2-a) or via a zinc-binding sub-
domain (Slac2-a) of unknown function
(FYVE-related domain). As shown in Fig-
ure 1, the overall structures of the two
complexes are similar, and there is an
obvious similarity to the previously deter-
mined structure of the Rab3A:Rabphilin
complex (Ostermeier and Brunger, 1999),
which, like Slac2-a, has a zinc-binding do-
main. Unlike Slac2-a, Slp2-a, and a num-
ber of other identified Rab27 effectors
that are highly specific, Rabphilin belongs
to a group of effectors that interact not
only with Rab27 but also with other exo-
cytic Rabs, in particular Rab3 and Rab8.
It is therefore of interest to compare the
structuresof the threedifferent complexes
to understand theorigins of the specificity.
In all three complexes, the main regions
of the Rab proteins involved in the inter-
actions are the CDRs (complementarity
determining regions [Ostermeier and
Brunger, 1999]) and the switch regions
(1 and II) that have GTP/GDP sensitive
conformations. Of the large number of
interactions that can be identified, some
of the most important (i.e., involving resi-
dues conserved between all three com-
plexes or that play a decisive role in spec-
ificity) are shown in the lower part of
Figure 1. In the report on the Rab27B:
Slac2-a structure, four Rab residues
were identified as key determinants for
the specific interaction of Slac2-a with
Rab27B rather than Rabphilin. These res-idues are Y6 from the N-terminal CDR,
and from switch II L84, F88, and D91. In
keeping with this, replacing these resi-
dues by their counterparts in Rab3A led
to reduction or complete loss of binding
of Rab27B to Slac2-a. Thus, the Y6F
and D91G mutants are reported to show
severely reduced Slac2-a binding, and
the quadruple mutant showed no detect-
able interaction. Conversely, replacement
of the four corresponding residues in
Rab3A by their Rab27B counterparts led
to significant Slac2-a binding activity. In
the report on the Rab27A:Slp2-a struc-
ture, it is suggested that Y122 of Rab27
(a single amino acid insertion in compari-
son with Rab3A) plays a crucial role in
the specific interaction with Slp2-a. How-
ever, a Rab27 mutant with this residue
mutated to cysteine still interacts with
Slac2-a (Fukuda, 2002) and it does not
appear to induce affinity for Slac2-a
when introduced into Rab3A.
The results reported in the two contribu-
tions to this issue of Structure significantly
extend our understanding of the specific-
ity of Rab-effector interactions. They
show that the differential interactions are
not caused by the principal changes of
effector structure but by the changes in
individual amino acids or small groups of
amino acids. Even here, the effects at the
structural level can be relatively subtle.
Thus, substitution of the key residue Y6
in Rab27B by its Rab3A phenylalanine
counterpart would not be expected to
destroy the hydrophobic interaction with
R35 in Slac2-a or R32 in Slp2-a, since
theRab3A:Rabphilin showsa similar inter-
action (with R71 in Rabphilin). However,
the additional -OH group on Y6 allows a
hydrogen bonding interaction to E32 in
Slac2-a and to E29 in Slp2-a. One of the
other key residues, D91 in Rab27A/B, al-
lows further interactions in addition to the
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PreviewsFigure 1. A Lock-and-Key Model of Rab-Effector Binding Specificity
The figure highlights structural features of the Rab27B:Slac2-a (left column), Rab3A:Rabphilin (middle column), and Rab27B:Slp2-a complexes (right column).
(Top panel) Key residues Y6(Rab27)/F19(Rab3A), F88(Rab27)/Y91(Rab3A), and D91(Rab27)/G94(Rab3A) are indicated as a ball-and-stick model in the three
Rab:effector-complexes together with their interacting partners. TheRab-proteins are shown as cartoonmodels; the effectors are drawn in ribbon representation.
(Bottompanel) Schematic overview of conserved amino acid interactions between Rab and the effector molecules. This representation emphasizes the role of the
key residues (boxed amino acids) as determinants for the interaction between Rab27B:Slac2-a, Rab3A:Rabphilin, and Rab27A:Slp2-a. The presence of Y6, F88,
and D91 permits Rab27 to bind to Slac2-a, Slp2-a, and Rabphilin. In contrast, the residues F19, Y91, and G94 allow Rab3A to bind to Rabphilin only. Blue dashes:
polar interactions; white dashes: hydrophobic interactions; SHD: Slp homology domains 1 and 2; red sphere: water molecule.van derWaals contacts seen in the case of
G94 in Rab3A. However, these interac-
tions are different in the Slac2-a and
Slp2-a complexes, with a water-mediated
side chain interaction in the former and
a side chain-backbone interaction in the
latter complex. In the contribution de-
scribing the Rab27A:Slp2-a complex, it
is suggested that a shift in the orienta-
tion of the conserved Rab-binding motif
(S/T)(G/L) x W(F/W)2 in Slp2-a compared1438 Structure 16, October 8, 2008 ª2008with the orientation in the Rab3A:Rabphi-
lin structure also contributes to specificity.
The different specificities of the Rab27
effectors discussed here appear to arise
as the sum of a number of relatively small
structural effects. Their detailed under-
standing is hampered at several levels,
one of which is connected with making
predictions about interaction-free ener-
gies based on determined structures.
Thus, it has been reported that Rab27AElsevier Ltd All rights reservedbinds to Slp2-a with ca. ten-fold higher
affinity than to Slac2-a (Fukuda, 2006).
However, there is no obvious explanation
for this on the basis of the structures pre-
sented. An additional problem is the fact
that there are not enough data on the
affinities and kinetics of Rab-effector in-
teractions, and on the effects ofmutations
on these. Thus, most of the statements
made here and in related publications
are based on pull-down experiments,
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misleading. The more quantitative data
mentioned above were obtained by sur-
face plasmon resonance (SPR) and have
been used as the basis for an initially
attractive model to explain the manner in
which Rab27 on the surface of melano-
somes is passed on from its interaction
with Slac2-a to allow transport, to its inter-
action with Slp2-a to allow docking onto
the plasma membrane (Fukuda, 2006).
However, there are many possible addi-
tional factors that could make a simple
comparison of affinities inadequate. For
example, the relative concentrations, or
local densities, of the effectors could
play a dominating effect. Another possi-
bility is that the FYVE-related domain ofTripping a Switch:
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Ras superfamily guanine nucleotide
for two-state molecular switches in
simplemodel. NowChen et al. (2008
‘‘trip’’ the nucleotide-dependent sw
also bind to its GDP state.
The ras superfamily of proteins provides
a common a/b fold to bind guanine nucle-
otides, either GTP or GDP. The terminal
phosphate group difference in the nucleo-
tides is accommodated by structural and
dynamic adjustments of several regions
of the fold, principally in so-called switch
regions. Regulatory proteins can sense
these conformational differences and
bind to G-proteins and small GTPases in
a GDP- or GTP-selective manner. Essen-
tially, without exception, the proteins are
active for signaling in the GTP-bound
state and are unable to bind effector pro-
teins, or bind them very weakly, in the
GDP state. This feature has made G-pro-
teins and small GTPases a paradigm forSlac2-a is, like the classical FYVE-do-
mains, a lipid-binding moiety and that an
interaction with the melanosome mem-
brane increases the effective affinity of
Rab27 to Slac2-a. As in many areas of
biology, real numbers are needed here
for affinities and rate constants, as well
as for effective concentrations of interac-
tion partners, before the system can be
understood quantitatively. The structures
presented here are an excellent starting-
off point for such an analysis.
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